SEARCH

SEARCH BY CITATION

References

  • 1
    Sakthivel S. Access to essential drugs and medicine in national commission of macroeconomics and heaalth background papers-health systems in India: delivery and financing of services, 2005; section III; 158184. Available from: http://www.whoindia.org/EN/Section102/Section201_887.htm[Accessed February 15, 2009.
  • 2
    Executive Order No. 175: Further Amending Republic Act 3720, Entitled “An Act to Ensure the Safety and Purity of Foods, Drugs, and Cosmetics Being Made Available to the Public by Creating the Food and Drug Administration Which Shall Administer and Enforce the Laws Pertaining Thereto,” as Amended, and for Other Purposes. Corazon C. Aquino, President of the Philippines. (May 22, 1987).
  • 3
    Republic Act 6675 “Generics Act of 1988” An Act to Promote, Require and Ensure the Production of an Adequate Supply, Distribution, Use and Acceptance of Drugs and Medicines Identified by their Generic Names. Corazon C. Aquino, President of the Philippines. (September 13, 1988).
  • 4
    Republic Act No. 7581 “The Price Act” An Act Providing Protection to Consumers by Stabilizing the Prices of Basic Necessities and Prime Commodities and by Prescribing Measures against Undue Price Increases during Emergency Situations and Like Occasions. (May 27, 1992).
  • 5
    Republic Act No. 7875 “The National Health Insurance Act of 1995” An Act Instituting a National Health Insurance Program for All Filipinos and Establishing the Philippine Health Insurance Corporation for The Purpose. Fidel V. Ramos, President of the Philippines. (February 14, 1995).
  • 6
    Republic Act No. 3720 “Food, Drug, and Cosmetic Act” An Act to Ensure the Safety and Purity of Foods, Drugs, and Cosmetics Being Made Available to the Public by Creating the Food and Drug Administration Which Shall Administer and Enforce the Laws Pertaining Thereto. (June 22, 1963) (Philippines)
  • 7
    Executive Order 102: Redirecting the Functions and Operations of the Department of Health. Joseph E. Estrada, President of the Philippines. (May 24, 1999).
  • 8
    MaHTAS—Health Technology Assessment Section, Ministry of Health Malaysia. 2008. Available from: http://www.inahta.org/Members/MaHTAs/[Accessed February 15, 2009.
  • 9
    Ministry of Health Malaysia. Health technology assessment list and technology review report. Available from: http://www.moh.gov.my/MohPortal/htaPublic.jsp[Accessed February 15, 2009.
  • 10
    Medical Device Bureau, Ministry of Health Malaysia. Placement of medical devices on the Malaysian market. 2008. Available from: http://www.mdb.gov.my/mdb/index.php[Accessed September 23, 2009.
  • 11
    National Pharmaceutical Control Bureau, Ministry of Health Malaysia. Annual Report 2006, ISSN 1985 – 336X.
  • 12
    Drug Control Organization, Ministry of Health Government of Pakistan. The Drugs Act (XXXI of 1976) [11 May 1976]. Available from: http://www.dcomoh.gov.pk/regulations/drugact1976.php[Accessed September 17, 2009.
  • 13
    Misra B, Jain S, Mehta Y. A study on availability and prices of medicines in India. 2002. Available from: http://www.nppaindia.nic.in/report/voicerep.html[Accessed February 16, 2009.
  • 14
    Department Order 238-T S. 2000. Authority for All Pndpp Compliance Officers and Food-Drug Regulation Officers in Bfad and Regional Field Offices to Monitor the Prices of 37 Essential Drugs on a Monthly Basis in Accordance with the Price Act of 1992. Susan P. Mercado, MD, MPH, Undersectretary of Health, Office of the Chief of Staff, Department of Health, Manila, Philippines. (July 3, 2000) (Philippines)
  • 15
    Administrative Order 2006-0009: Guidelines Institutionalizing and Strengthening the Essential Drug Price Monitoring System (Edpms). Francisoo T. Duque Iii, MD, MSc, Secretary of Health, Manila, Philippines (February 14, 2006).
  • 16
    Republic Act No. 9502: Universally Accessible and Cheaper Quality Medicines Act of 2008. An Act Providing for Cheaper and Quality Medicines, Amending for the Purpose Republic Act No. 8293 or the Intellectual Property Code, Republic Act No. 6675 or The Generics Act of 1988, and Republic Act No. 5921 or The Pharmacy Law, and for Other Purposes. Gloria Macapagal-Arroyo, President of the Philippines (June 6, 2008).
  • 17
    Administrative Order No. 2006-0009. Guidelines Institutionalizing and Strengthening the Essential Drug Price Monitoring System (Edpms). Francisto T. Duque Iii, MD, MSc, Secretary of Health, Manila, Philippines (February 14, 2006).
  • 18
    Amanullah, Cost Accountant, Drug Control Organization, Personal Communication on 28th July 2008. (Pakistan)
  • 19
    Sujatha R. Health insurance in India. National Commission on Macroeconomics and Health Background Papers-Health Systems in India: Delivery and Financing of Services; Section IV, pp. 27595.
  • 20
    De Oude W, Krishnamurthy R. The health insurance industry in India and its growing potential. Available from: http://www.watsonwyatt.com/europe/pubs/healthcare/render2.asp?ID=15251[Accessed February 15, 2009.
  • 21
    Republic Act No. 7875 “National Health Insurance Act of 1995”: An Act Instituting a National Health Insurance Program for All Filipinos and Establishing the Philippine Health Insurance Corporation for the Purpose. Fidel V. Ramos, President of the Philippines (February 14, 1995).
  • 22
    Executive Order No. 49: Directing the Mandatory Use of the Philippine National Formulary (Pndf) Volume I as the Basis for Procurement of Drug Products by the Government. Fidel V. Ramos, President of the Philippines (January 21, 1993).
  • 23
    Philhealth Board Resolution No. 265 and Full Implementation of the Principles of Good Prescribing. Alberto G. Romulaldez, Jr, MD, Philhealth Board Chairperson and Secretary of Health Manila, Philippines (July 15, 1999).
  • 24
    Administrative Order No. 2006-0018 Implementing Guidelines for the Philippine National Drug Formulary System. Francisco T. Duque Iii, MD, MSc, Secretary of Health, Manila, Philippines (May 8, 2006).
  • 25
    The National Formulary Committee of the National Drug Policy, Pharma 50 Project Management Unit, Department of Health. Philippine National Drug Formulary Essential Drugs List (Vol. I, 6th ed.) Manila, 2005:1412.
  • 26
    The National Formulary Committee of the National Drug Policy, Pharma 50 Project Management Unit, Department of Health. Preface of the Philippine National Drug Formulary Essential Drugs List (Vol. I, 6th ed.). Manila: 2005:v.
  • 27
    World Health Organization, Health System Profile: Pakistan, Regional Health System Observatory, Eastern Meditation Region (EMRO), 2007.
  • 28
    Sujatha R, Selvaraju S, Nagpal S, Sakthivel S. Financing of health in India. National Commission on Macroeconomics and Health Background Papers-Health Systems in India: Delivery and Financing of Services; Section IV, 23955.
  • 29
    National Pharmaceutical Control Bureau, Ministry of Health Malaysia. 2006. Available from: http://www.pharmacy.gov.my/html/annual_report2006_bm.htm[Accessed September 2009.
  • 30
    National Assembly, Constitution of Islamic Republic of Pakistan 1973, Schedule 4, Federal Concurrent List, Government of Islamic Republic of Pakistan, 1973.
  • 31
    World Health Organization, Health System Profile: Pakistan, Regional Health System Observatory, Eastern Mediterranean Region, 2006.